Bertrand Napoléon

Bertrand Napoléon

Auto-generated profile, based on publicly available information

Bertrand Napoléon

Lyon

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2003 in Endoscopy
Verified
Journal Article
Closed access
PDF file
BNB. Napoléon
B. Napoléon
JDJ. Dumortier
J. Dumortier
OKO. Keriven-Souquet
O. Keriven-Souquet
BPB. Pujol
B. Pujol
TPT. Ponchon
T. Ponchon
JSJ.-C. Souquet
J.-C. Souquet
Background and Study Aims: Biliary endoscopic ultrasonography (EUS) and endoscopic retrograde cholangiography (ERC) are equally accurate for the diagnosis of common bile duct (CBD) stone. The aim of this prospective 1-year follow-up study was to determine whether normal findings at initial EUS obviated the need for ERC. Patients and Methods: During a 17-month period, all patients referred for biliary EUS because of suspicion of CBD stone, in whom EUS findings were normal were included in the study. Early (1-month) and late (1-year) follow-up details were obtained by mail or telephone. The clinical course and need for ERC were recorded. Results: 238 patients were enrolled. During follow-up, 59 (25 %) patients underwent cholecystectomy, with (n = 31) or without (n = 28) cholangiography, and 30 patients underwent ERC (13 %). CBD stone was found in 14 (6 %) patients. Of these 30 patients, ERC was done in 15 cases in the first week after EUS, because of persistent suspicion of a CBD stone which was found in 10 patients. The 15 late ERC procedures (carried out more than 1 week after EUS) revealed only one CBD stone. The negative predictive value of EUS for the diagnosis of CBD stones was 95.4 %. Conclusions: Patients with suspicion of CBD stones but normal EUS findings have a low risk of needing ERC in a 1-year period.

14 March 2006 in Endoscopy
Verified
Journal Article
Open access
PDF file
BNB. Napoléon
B. Napoléon
BBB. Boneu
B. Boneu
LML. Maillard
L. Maillard
CSC.-M. Samama
C.-M. Samama
JSJ.-F. Schved
J.-F. Schved
JCJ.-M. Canard
J.-M. Canard
Managing patients who are taking Vitamin K Antagonists (VKA) or antiplatelet agents (APA) is a common problem before performing digestive endoscopy. Although risks concerning bleeding are the remit of both the gastroenterologist and anaesthetist, the potential risk of interruption of antithrombotic treatment for the patient should not be underestimated. Faced with the wide variety of situations, it is difficult to lay down rules which cover all circumstances and there are few reference guidelines [ 1 ] [ 2 ] [ 3 ]. Ideally, changes of treatment ought to be made in consultation with the doctor who initially prescribed the treatment with estimation of the risk/benefit ratio bearing in mind alterations to the antithrombotic treatment. This has to be tailored to individual patients on a case-by-case basis.This ideal situation is rare. Often the patient cannot remember the reference physician or the latter cannot be contacted. Other factors rendering such strategies difficult and complex include differences of opinion or lack of knowledge about the respective risks of stopping antithrombotic treatment or of not performing the endoscopy, lack of data in the literature, etc. However, in practice there are some data on which to base a decision. Three factors should be taken into account: the risk of haemorrhage from the procedure, the antithrombotic treatment used and the risk of thromboembolism when the treatment is withdrawn. In an attempt to reach the broadest possible consensus, the French Society of Digestive Endoscopy (SFED), the Study Group on Haemostasis and Thrombosis (GEHT) of the French Society of Haematology, the French Society of Cardiology (SFC) and the French Society of Anaesthesiology and Intensive Care Medicine (SFAR) have joined forces and put forward these recommendations. Of course, they are still only temporary guidelines and are likely to change over time as scientific knowledge accrues.

25 February 2015 in Endoscopy
Verified
Journal Article
Closed access
BNB Napoleon
B Napoleon
ALAi Lemaistre
Ai Lemaistre
BPB Pujol
B Pujol
FCFabrice Caillol
Fabrice Caillol
FFF Fumex
F Fumex
MGM Giovannini
M Giovannini
Résumé: Introduction: L'endomicroscopie confocale par minisonde au travers d'une aiguille (nCLE: needle-based Confocal Laser Endomicroscopy) est une technique d'imagerie permettant de réaliser un examen microscopique in vivo et en temps réel, au cours d'une procédure d' échoendoscopie avec ponction (EE-P). Une étude prospective multicentrique française (CONTACT), a pour objectif d'évaluer les performances de la nCLE pour le diagnostic des kystes pancréatiques uniques chez des patients sans pancréatite chronique avérée, ni communication évidente en imagerie. Des critères d'interprétation ont été définis dans la première phase de l'étude: la papille pour le diagnostic de TIPMP, le maillage vasculaire superficiel (MVS) pour le diagnostic de cystadénome séreux (CS), le champ de particules brillantes pour le diagnostic de pseudokyste (PK) et la bordure épithéliale pour celui de cystadénome mucineux (CM). Une première validation de ces critères a été réalisée rétrospectivement par les investigateurs de l'étude, experts en nCLE. Les résultats mettaient en évidence une spécificité de 100% pour le diagnostic de CS ainsi que pour la distinction entre lésions mucineuses et non-mucineuses. La concordance inter-observateurs globale était bonne pour le diagnostic de CS et de pseudokyste et pour la distinction entre lésion mucineuse et non- mucineuse. But: Evaluer quelles sont les performances d'observateurs novices en nCLE pour le diagnostic de nature des kystes pancréatiques basés sur ces signes. Matériels et Méthodes: Lors d'une session commune, les quatre gastroentérologues non experts en nCLE (CL, VL, FF, LP) ont visionné le 3 Décembre 2013 10 vidéos indépendantes de cas leur présentant les critères pour chaque type de kyste (3 CM, 2 TIPMP, 3 CS et 2 PK). Secondairement ils visualisaient les enregistrements de nCLE des 31 patients de l'étude CONTACT 1, individuellement, en ordre aléatoire et à l'aveugle des données cliniques et radiologiques. Ils devaient conclure à un diagnostic: CS, PK, TIPMP, CM, ou répondre indéterminé en l'absence de visualisation des critères. L'accord inter-observateur était évalué. Dans une seconde phase, les observateurs ont revu uniquement les cas discordants, pour établir, si possible, un consensus. Les résultats étaient comparés au diagnostic final. Résultats: L'accord entre les observateurs était total dans 32% des cas et un consensus était obtenu dans tous les cas discordants. Un diagnostic était porté dans 71% des cas, 29% restant indéterminés. Discussion: Conclusion: Les résultats obtenus par les observateurs non experts en nCLE sont en accord avec les résultats obtenus par les investigateurs initiaux. L'excellente spécificité pour le diagnostic du CS et les très bonnes spécificités des autres critères sont maintenues, ce qui laisse envisager une courbe d'apprentissage rapide et le fort impact clinique que peut avoir la nCLE. Une validation prospective des performances de la nCLE est en cours afin de confirmer ces résultats. Structure: Endoscopie - imagerie

1 September 1993 in Endoscopy
Verified
Journal Article
Closed access
JSJ. C. Souquet
J. C. Souquet
BNB. Napoleon
B. Napoleon
BPB. Pujol
B. Pujol
TPT. Ponchon
T. Ponchon
OKO. Keriven
O. Keriven
RLR. Lambert
R. Lambert
Echoendoscopy has been found useful to better define gastrointestinal tract tumors which may be suitable for endoscopic treatment. In benign tumors, echoendoscopy may be used to decrease the risk of hemorrhage or perforation before resection of large polyps or submucosal lesions. The most important indications for echoendoscopy, however, are in the field of GI oncology, and the method may lead to a better selection of superficial cancers without lymph node metastases. However, endoscopic ultrasound is still limited in differentiating mucosal from submucosal tumors and in the detection and interpretation of small lymph nodes. Technical improvements and careful interpretation of echoendoscopy will increase the number of patients cured by non-surgical procedures in the future.

1 April 2004 in Gastroentérologie Clinique Et Biologique
Verified
Journal Article
Closed access
BNBertrand Napoléon
Bertrand Napoléon
JPJean Pialat
Jean Pialat
JSJean-Christophe Saurin
Jean-Christophe Saurin
JSJean-Yves Scoazec
Jean-Yves Scoazec

1 December 2004 in Endoscopy
Verified
Journal Article
Closed access
PDF file
MBM. Barthet
M. Barthet
BNB. Napoleon
B. Napoleon
GGG. Gay
G. Gay
TPT. Ponchon
T. Ponchon
DSD. Sautereau
D. Sautereau
BVB. Vedrenne
B. Vedrenne
The aim in antibiotic prophylaxis is to prevent general and local infectious complications related to a medical procedure. General complications are rare in digestive endoscopy (five cases of endocarditis have been reported in the English-language literature [ 1 ]), but the rate of local complications can reach 1 % for certain procedures (such as endoscopic retrograde cholangiopancreatography, ERCP). The benefits of antibiotic prophylaxis should be weighed up against: Its cost, which is not negligible (depending on the number of endoscopies carried out). The risk of selecting resistant bacteria 2 3 4 5 6 7. The lack of absolute efficacy in preventing endocarditis and local infections, as noted in controlled studies. The high levels of bacteremia also reported in everyday procedures (such as cleaning the teeth). The risk of causing anaphylactic shock or allergic symptoms, the severity of which may be variable. The use of antibiotic prophylaxis must be justified. These recommendations take into account both the risks associated with the endoscopic procedure and risks inherent to the patients themselves.